31 studies found for:    polyphenon
Show Display Options
Rank Status Study
1 Active, not recruiting Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia
Condition: Prostatic Hyperplasia
Interventions: Drug: Polyphenon E;   Drug: placebo
2 Completed Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer
Condition: Bladder Cancer
Interventions: Dietary Supplement: Polyphenon E;   Drug: erlotinib hydrochloride;   Other: Erlotinib placebo;   Other: Polyphenon E
3 Terminated
Has Results
Safety and Neuroprotective Effects of Polyphenon E in MS; Phase II
Condition: Multiple Sclerosis
Interventions: Drug: Polyphenon E;   Other: Placebo
4 Unknown  Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected Individuals
Condition: HIV Infection
Intervention: Drug: Polyphenon E
5 Completed Study of Polyphenon E in Addition to Erlotinib in Advanced Non Small Cell Lung Cancer
Condition: Advanced Non-Small Cell Lung Cancer
Intervention: Drug: Polyphenon E +Tarceva (Erlotinib)
6 Completed
Has Results
Safety of Polyphenon E in Multiple Sclerosis Pilot Study
Condition: Multiple Sclerosis
Intervention: Drug: Polyphenon E
7 Completed Efficacy and Safety Study of Polyphenon E to Treat External Genital Warts
Condition: Condylomata Acuminata
Intervention: Drug: Polyphenon E Ointment 10%, Polyphenon E Ointment 15%
8 Completed
Has Results
Green Tea or Polyphenon E in Preventing Lung Cancer in Former Smokers With Chronic Obstructive Pulmonary Disease
Condition: Lung Cancer Prevention
Interventions: Dietary Supplement: green tea;   Drug: Polyphenon E;   Other: placebo
9 Recruiting Phase I Chemoprevention Trial With Green Tea Polyphenon E and Erlotinib in Patients With Premalignant Lesions of the Head and Neck
Conditions: Cancer of Head and Neck;   Neoplasms, Head and Neck
Intervention: Drug: Erlotinib and Green Tea Polyphenon E
10 Active, not recruiting
Has Results
A Study of the Effect of Polyphenon E (Green Tea Extract) on Breast Cancer Progression
Condition: Breast Cancer
Intervention: Drug: Polyphenon E
11 Completed Treatment of Epidermolysis Bullosa Dystrophica by Polyphenon E (Epigallocatechin 3 Gallate)
Condition: Epidermolysis Bullosa Dystrophica
Interventions: Drug: Polyphenon E before Placebo;   Drug: placebo before treatment
12 Recruiting Polyphenon E in Treating Patients With High-Risk of Colorectal Cancer
Conditions: Advanced Colorectal Adenomas;   Adenocarcinoma of the Colon;   Stage I Colon Cancer;   Stage II Colon Cancer;   Stage III Colon Cancer
Interventions: Drug: defined green tea catechin extract;   Other: placebo;   Other: questionnaire administration;   Other: laboratory biomarker analysis
13 Completed Pilot Study of Green Tea Extract (Polyphenon E®)in Ulcerative Colitis
Condition: Mild to Moderately Active Ulcerative Colitis
Intervention: Drug: Polyphenon E®
14 Terminated Green Tea Extract in Treating Patients With Nonmetastatic Bladder Cancer
Conditions: Stage I Bladder Cancer;   Stage II Bladder Cancer;   Stage III Bladder Cancer
Interventions: Dietary Supplement: defined green tea catechin extract;   Drug: placebo;   Procedure: therapeutic conventional surgery;   Other: pharmacological study;   Other: laboratory biomarker analysis
15 Terminated Green Tea Extract in Treating Patients With Actinic Keratosis
Condition: Non-melanomatous Skin Cancer
Intervention: Drug: Polyphenon E and Placebo
16 Completed Green Tea Extract (Polyphenon E) in Preventing Cancer in Healthy Participants
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Dietary Supplement: defined green tea catechin extract
17 Completed Pharmacokinetic Study of Topically Applied Veregen 15% Compared With Oral Intake of Green Tea Beverage
Conditions: Genital Warts;   Perianal Warts
Interventions: Drug: Polyphenon E (Veregen) 15% ointment;   Other: Green Tea Beverage with defined catechin content
18 Completed
Has Results
Green Tea Extract in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
Condition: Leukemia
Intervention: Biological: Polyphenon E
19 Terminated Defined Green Tea Catechin Extract in Treating Patients With Localized Prostate Cancer Undergoing Surgery
Conditions: Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer
Interventions: Dietary Supplement: defined green tea catechin extract;   Other: placebo;   Other: immunohistochemistry staining method;   Other: immunoenzyme technique;   Other: questionnaire administration;   Procedure: therapeutic conventional surgery;   Other: high performance liquid chromatography;   Other: mass spectrometry
20 Unknown  Treatment of the Recessive Nonbullous Congenital Ichthyosis by the Epigallocatechine Cutaneous
Condition: Lamellar Ichthyosis
Intervention: Drug: apply VEREGEN ® 10 % on a randomized area and the moisturizing cream of the other side

Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results
Indicates status has not been verified in more than two years